ArticleEuropean journal of radiology open2025
Limited additional value of dual-layer spectral 4DCT compared with conventional 4DCT for preoperative localization in primary hyperparathyroidism.
Article in European journal of radiology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Primary hyperparathyroidism, characterized by excessive parathyroid hormone secretion, is typically caused by solitary parathyroid adenomas or multiglandular disease. Accurate preoperative localization is critical for successful surgical parathyroidectomy. While four-dimensional CT (4DCT) is commonly used for this purpose, spectral-CT techniques have recently been introduced, offering improved tissue differentiation. Rapid kV switching and dual-source spectral-CT have been studied, however, this is the first study that evaluates the effectiveness of dual-layer-CT in preoperatively locating parathyroid adenomas in a larger population. Approach: From April 2020 to October 2023, patients with confirmed primary hyperparathyroidism underwent dual-layer spectral 4DCT before surgery. Spectral reconstructions (MonoE40keV, Iodine-Density, Z-effective, Iodine-no-Water, Virtual Non-Contrast) were analyzed alongside conventional CT reconstructions. Mean attenuation values were compared using one-way ANOVA. ROC curves with paired-sample analysis assessed the ability of different reconstructions to distinguish between thyroid and parathyroid tissue, and lymph nodes and parathyroid tissue. Results: Thirty-six patients with thirty-nine parathyroid adenomas were analyzed. Conventional CT reconstructions demonstrated significantly higher AUC values for differentiating thyroid from parathyroid tissue across all phases compared to spectral reconstructions (0.83-0.95 vs. 0.65-0.89, p-value 0.007-<0.001). No significant difference was found between conventional and spectral reconstructions in distinguishing lymph nodes from parathyroid tissue (0.64-0.96 vs. 0.58-0.96, p-value 0.070-0.957). Virtual non-contrast (VNC) reconstructions showed smaller attenuation differences and lower AUC values in arterial and delayed phases compared to true non-contrast (p = 0.031 and 0.034). Conclusions: Dual-layer spectral-CT is comparable or inferior to conventional CT in tissue differentiation. VNC reconstructions are not recommended as a substitute for true non-contrast due to inconsistent results. In this cohort, dual-layer spectral 4DCT did not demonstrate clear clinical advantage; further validation is warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.